Puma Biotechnology (PBYI) Net Cash Flow Growth (1y) (2012 - 2026)
Puma Biotechnology (PBYI) Net Cash Flow Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -88.82% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 301.06% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 453.08% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -125.22% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Puma Biotechnology | 409.56 Mn | 371.27 Mn | 34.39 Mn | 205.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 205.96% |
| Dec 31, 2025 | -1,321.37% |
| Sep 30, 2025 | -1,097.37% |
| Jun 30, 2025 | 12.85% |
| Mar 31, 2025 | 21.00% |
| Dec 31, 2024 | -14.40% |
| Sep 30, 2024 | -99.48% |
| Jun 30, 2024 | -592.29% |
| Mar 31, 2024 | 47.09% |
| Dec 31, 2023 | 229.90% |
| Sep 30, 2023 | -13.53% |
| Jun 30, 2023 | 88.32% |
| Mar 31, 2023 | -83.53% |
| Dec 31, 2022 | -115.56% |
| Sep 30, 2022 | 197.31% |
| Jun 30, 2022 | -104.60% |
| Mar 31, 2022 | -177.88% |
| Dec 31, 2021 | 82.96% |
| Sep 30, 2021 | -3,078.04% |
| Jun 30, 2021 | -182.82% |